Marketing-authorisation holder · Canada
Biolyse Pharma Corporation
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DOCETAXEL INJECTION20 mg / ml · Solution | Docetaxel | Canada | Marketed | 2017 |
| FLUOROURACIL INJECTION5 g / 100 ml · Solution | Fluorouracil | Canada | Marketed | 2019 |
| FLUOROURACIL INJECTION0.5 g / 10 ml · Solution | Fluorouracil | Canada | Marketed | 2021 |
| PACLITAXEL FOR INJECTION6 mg / ml · Solution | Paclitaxel | Canada | Marketed | 2001 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 4 | 4 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.